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The present study examined the neuro-electrophysiological activity of the brain associated with the application of a herbal remedy
developed by a Shaolin monk based upon the Chan healing principle of clearing the orifices (i.e., the nasal cavities). A repeated-
measures design was used. Fourteen normal adults were administered herbal remedy and saline solution intranasally on separate
sessions. Two intervals of eyes-closed resting EEG data were obtained individually before and after each administration. Results
showed that only the herbal remedy but not the saline solution induced elevation in cordance, an index correlated with cerebral
perfusion, in the anterior brain region. In addition, the activity of the anterior cingulate cortex (ACC), as examined by the LORETA
analysis, was also increased after the application of the herbal remedy but not saline solution. The present study provided some
preliminary evidence suggesting that the herbal nasal drop enhanced the activity of the frontal lobe and ACC. Implications for the
potential clinical application of the herbal remedy to treat patients with frontal lobe disorders were discussed.
1. Introduction
The traditional Shaolin Buddhism training required the
practicing monks to be fluent in Shaolin Kungfu, Chanwu
(martial arts that focus on training Qi and Mind), and a
unique healing method, Chanyi (healing approach based
upon the principle of unblocking Qi and clearing orifices).
The term Chanwuyi (Chan, martial arts and medicine) has
been created to describe the uniqueness of this training.
The last author of this article is a Shaolin monk who has
been practicing Chanwuyi for over 20 years and is renowned
in China for having treated many patients with illnesses
that seemed untreatable. Some empirical studies have been
conducted to evaluate the eﬀectiveness of this method [1, 2]
and found positive eﬀects. The first author has also reviewed
many cases and interviewed many of the last author’s
patients including late-stage cancer patients, patients with
stroke and children with mental retardation. These patients
demonstrated various degrees of improvement, including
improved motor function, reduced obsessive behavior and
improved life expectancy. One of the treatment methods
used by the last author was a herbal formula developed
by himself and his master based upon the Shaolin healing
principle of clearing the orifices, according to which all
openings of the body are orifices and the nose is the most
important orifice in healing illnesses. Therefore, the herbal
formula, in the form of liquid drops, is administered through
the nasal cavities for clearing this major orifice.
Initial clinical observations on the herbal nasal drop on
patients with diﬀerent brain disorders, including patients
with brain tumor, mental retardation and schizophrenia,
have found positive eﬀects. This is especially encouraging as
no western drug intervention is presently available for cog-
nitive impairment resulting from brain disorders. Patients
being administered the herbal remedy have demonstrated
20%–80% improvement in their conditions [3]. We have
been using this herbal nasal drop on patients with diﬀerent
brain disorders for 1 year, and the results are very encourag-
ing. For instance, one patient who has demonstrated frontal
lobe dysfunction for almost 3 years resulting from epilepsy
and stroke has received the herbal nasal drop treatment
for 4 months. At baseline, this patient demonstrated many
signs of frontal lobe dysfunction including (i) expressive
diﬃculty (i.e., at most three words per conversation), (ii)
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impairment in comprehension (i.e., could only execute one-
component command), (iii) irritability and bad temper
(i.e., uncooperative on tasks) and (iv) blunt aﬀect (i.e.,
no emotional response to praise or reprimand). After a 4-
month treatment with the herbal nasal drop, he showed
improvement in communication (COM) and social-and-
cognitive (SOC-COG) abilities, as measured by the subscales
of the Functional Independence Measure (FIM) [4]. His
score increased from 5/14 to 7/14 (40% increment) in the
COM subscale and from 4/21 to 7/21 (75% increment) in
the SOC-COG subscale. Specifically, after the intervention,
his verbal expression was improved and he could produce
up to five words per conversation and could execute four-
component commands. Overall, his quality of life, as mea-
sured by the Quality of Life Index (QoLI) [5], has improved
from 3 to 7.5 out of 10 points.
Consistent results were obtained from a pilot study on
a group of children with frontal lobe dysfunction who
demonstrated impairment on spontaneous speech output,
inhibition on repetitive speech and initiation of behavior.
Six children were administered herbal nasal drop intranasally
for a month, and six age- and intelligence-matched children
received a saline solution as control. Treatment-related
changes were rated by their parents who were blinded to
the group assignment, on an 11-point rating scale (from
−5 to +5), where negative rating indicated deterioration,
positive rating indicated improvement and zero indicated no
change. Initial findings indicated that the treatment group,
as compared with the control group, showed significantly
greater improvement in spontaneous speech output (mean
score: treatment group = 2.24, control group = 0.09, P <
.01), inhibition on repetitive speech (mean score: treatment
group = 1.14, control group = 0, P < .05) and initiation
of behavior (mean score: treatment group = 2.6, control
group = 0.33, P < .05). Thus, these encouraging results
of our pilot data on both adult and children patients with
frontal lobe dysfunction suggested that this herbal formula
may have a positive eﬀect on frontal lobe dysfunction. While
the clinical trails are on-going, the present study aimed
to study the brain activities underlying the intervention
eﬀect of this herbal medicine using neuro-eletrophysiological
methods. The frontal lobe and anterior cingulate cortex
(ACC) (Figure 1) were chosen as two regions of interest as
they are significant in mediating frontal lobe function.
Diﬀerent methods have been used to study the brain
activities and functioning, and quantitative electroen-
cephalography (QEEG) has been one of the widely accepted
non-invasive method for this purpose. Two quantitative
QEEG measures, cordance [6, 7] and low-resolution electro-
magnetic tomography (LORETA) [8, 9], have been used to
examine brain activities [7, 10–14]. Cordance was developed
by Leuchter and colleagues [6] as a non-invasive method
that might be used as an index associated with brain
perfusion. Brain perfusion reflects the amount of blood
flow to the brain tissues, with higher perfusion suggesting
higher metabolism in that region. The cordance value was
found to be moderately correlated with cerebral perfusion as
measured by the positron emission tomography (PET) [6],
and this method has been used to study brain activities in
Anterior cingulate cortex
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Figure 1: Graphical illustration of the sagittal view of frontal lobe
(in yellow) and anterior cingulate cortex (ACC, in blue) in a human
brain.
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Figure 2: The change in mean anterior cordance values before and
after the administration of the herbal nasal drop and saline nasal
drop.
patients with depression [15], brain damage [7] and autism
[10]. This method was used in the present study to evaluate
the eﬀect of the herbal formula on the activity of the frontal
region.
The ACC, lying on themedial surfaces of the frontal lobes
(Figure 1), is another region of interest in the present study
because it is significant in mediating frontal lobe functions.
The ACC has been found to have neuronal projections to
virtually all areas of the frontal cortex [16] and is functionally
connected with the frontal lobe [17]. The functions of ACC
were inter-related to that of frontal lobe functions, which
has been well documented to mediate cognitive processes
involving inhibitory control andmonitoring of emotions and
behaviors under conflicting situations [18, 19]; the ability
to detect erroneous stimuli and response [18]; and eﬃcient
allocation of attention to accomplish an eﬀortful cognitive
task [19, 20]. Previous findings implicated the ACC as one
of the neuronal generators for theta activity in the human
brain [14, 21, 22], and LORETA analysis has been one of
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the common methods used for studying source activity of
ACC. Increased theta source activity at ACC localized by
the LORETA method has been found to be correlated with
increased metabolism at ACC as measured by the PET [23].
LORETA was thus used in this study to examine the eﬀect of
the herbal nasal drop on ACC activity of normal adults.
2. Method
2.1. Study Design and Participants. A repeated-measures
design was used with each participant being administered
both the herbal formula (experimental condition) and saline
(control condition) nasal drops. The order of administration
of the two nasal drops was counter-balanced across partic-
ipants to reduce order eﬀect. The study was performed in
accordance with the Helsinki Declaration. Voluntary partic-
ipation with informed consent was solicited from 14 right-
handed normal adults in Hong Kong. Participants (male =
6, female = 8) were aged between 25 and 51 years (mean age
= 38.29 years) and had attained university graduate level of
education. All participants reported no prior history of head
injury, neurologic or psychiatric disorders.
2.2. Procedure. EEG was recorded individually in a sound
and light-attenuated room during the nasal administration
of the herbal formula (experimental condition) or saline
(control condition) nasal drops. The two conditions were
applied with at least 1 h inter-session interval. In each
recording session, the participant lay on his or her back on
a bed while the experimenter explained the procedure before
he or she was hooked up for EEG recording. A 5-min baseline
eyes-closed resting EEG recording was then taken, followed
by the application of 10ml of either the experimental or
control agent to the nasal cavities of the participant by the
experimenter that lasted for about 5min. All participants
were blinded to the experimental conditions. The two agents
were applied with an Eppendorf Multipette plus pipette, in
20 droplets of 0.5ml each. Then, an eyes-closed resting EEG
recording was taken after the administration.
2.3. Materials
2.3.1. Herbal Nasal Drop. The herbal nasal drop was pro-
vided by the Institute of Chan Herbal Medicine under
the Chanwuyi Foundation Limited (a registered charity
organization in Hong Kong) and was manufactured under
strict Good Manufacturing Practice (GMP) standards. The
product has been tested on the level of heavy metal and toxic
elements, microbial examination and pesticides residue. The
testing results met the product safety guidelines set forth
by the Department of Health of the Government of Hong
Kong. Some major ingredients include Herba Artemisiae
Annuae, Rhizoma Coptidis and Borneol, in a ratio of
1 : 1 : 0.5 and were dissolved in distilled water. All herbal
ingredients in the present formula are within the allowed
daily dosages as prescribed in the Chinese Herbal Medicine
published by the Educational Board of the National Drug
Administration.
2.3.2. Saline Nasal Drop. A sodium chloride (0.9%) solution
commonly used for washing the sinus was used in this study
as the control condition.
2.4. Data Analysis. Resting EEG data were collected in
the eyes-closed condition using an electrode cap with 19
electrode sites (International 10–20 System) referenced to
linked ears. The EEG signal was digitized at 256Hz with
a low pass filter of 30Hz and impedances below 10 kΩ.
Body movements were recorded for oﬀ-line analyses. EEG
data were visually examined for eye movements and muscle
artifacts. Only data that had at least 1min of artifact-
free data were selected [24] and spectrally processed using
the fast Fourier transformation (FFT) to compute absolute
and relative power data for subsequent calculation of the
cordance indices. The source of the scalp EEG power
measured was localized using the LORETAmethod. The data
were selected and processed by a research assistant who was
blinded to the experimental conditions.
Cordance values at theta (4–8Hz) frequency band was
computed for 19 electrode sites (Fp1, Fp2, F3, F4, F7,
F8, Fz, T3, T4, T5, T6, C3, C4, Cz, P3, P4, Pz, O1 and
O2) according to the methods reported by Leuchter and
colleagues [7, 15]. The 19 cordance values were averaged
to form three regional mean values, namely the anterior
(Fp1, Fp2, F3, F4, F7, F8, Fz and Cz), centrotemporal
(T3, T4, T5, T6, C3 and C4) and posterior regions (P3,
P4, Pz, O1 and O2). The anterior cordance value was the
region of interest in the present study, which may possibly
reflect the cerebral perfusion of the frontal lobe. For the
LORETA source localization method [8, 9], the sources of
the theta band computed from scalp electrical potentials
were expressed as 3D cortical current density according to
the Talairach brain atlas and were analyzed with a freeware
(http://www.uzh.ch/keyinst/loreta.htm). The cordance data
were compared using analysis of variance (ANOVA) with
repeated measures to examine whether the herbal nasal
drop has an eﬀect on brain activities over and above
the control condition. LORETA data were also compared
between baseline resting and post-nasal drops application
using the paired t-tests on 2394 voxels with subject-wise
normalization process. The aim was to examine whether
application of the herbal nasal drop was associated with
diﬀerent sources of scalp EEG as compared with application
of the saline solution.
3. Results
3.1. Analyses on the Activity of the Frontal Cortex. A condition
(herbal nasal drop versus saline nasal drop) by time (pre- ver-
sus post-nasal drop application) repeated-measures ANOVA
was performed to compare the theta cordance measured at
the anterior brain region. The multivariate results showed
a significant interaction eﬀect, F(1,13) = 7.01, P < .05.
Subsequent post hoc paired t-tests indicated that the anterior
cordance value at post-application of the herbal nasal drop
was significantly higher than that at the baseline condition
(t(13) = −3.80, P < .01) with a large eﬀect size of 1.01,
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whereas the diﬀerence in anterior cordance values before and
after the administration of saline solution was nonsignificant
(t(13) = −0.76, P > .05). Participants’ anterior cordance
values at the baseline condition before the application of
both nasal drops were comparable (t(13) = 2.08, P > .05).
The change in anterior cordance values after the application
of the herbal nasal drop (mean increment = 0.64) was
significantly greater than that of the saline solution (mean
increment = 0.09) (t(13) = 2.65, P < .05) (Figure 2).
Contrasting with the cordance value at the anterior region,
both centrotemporal and posterior cordance values did not
show similar enhancement in either of the experimental
condition (F = 0.01 and 3.68, P = .93 and .08, resp.). The
relatively robust and specific increase in anterior cordance
may be suggestive of the eﬀect of the herbal nasal drop in
enhancing cerebral blood flow to the frontal lobe.
To examine the validity of cordance (i.e., whether the
eﬀect of the herbal nasal drop is specific to cordance measure
or if any EEG measure may yield the same results), other
EEG measures were examined. Leuchter and colleagues
[7] reported that only EEG cordance, but not absolute
and relative power, yielded the strongest relationship with
cerebral perfusion. Thus, condition (herbal nasal drop
versus saline nasal drop) by time (pre- versus post-nasal
drop application) repeated-measures ANOVA analyses were
conducted separately for absolute and relative theta power.
The mean absolute and relative power was calculated sepa-
rately by averaging across the electrodes within the anterior
scalp regions as that of mean cordance computation. No
significant interaction eﬀect was found in either absolute or
relative theta power in the anterior brain region (F (1,13) =
0.07 and 3.86, P > .05), suggesting that the administration
of the herbal nasal drop had a specific eﬀect on increasing
the cordance level, which is an indicator of enhanced brain
activity.
3.2. Analyses on the Activity of the Anterior Cingulate Cortex.
Further to the previous analysis of theta cordance as a
measure of the general level of activity of the frontal cortex,
we also focused specifically on the activity of the ACC.
The LORETA voxel-by-voxel paired t-test with subject-wise
normalization on the log-transformed data was performed
separately for the herbal and saline nasal drop conditions.
With repeated tests performed, the alpha was set at 0.025
with Bonferroni adjustment, and the corresponding signif-
icant t-threshold was at 2.65 (df = 13). Figure 3 shows
the graphical representation of the LORETA t-statistics
separately for each nasal drop condition. It was found that
administration of the herbal nasal drop was associated with a
significant increase in theta source activity maximally at the
ACC (BA 24 and 32) (t = 4.02, P < .025), while no such
increase was observed for the saline condition (P = .07).
In addition to ACC activation, an increase in theta source
activity associated with herbal nasal drop was also found in
some frontal structures, including the middle and superior
frontal gyri (BA 8 and 10) (P < .025).
Given that the herbal nasal drop and saline solution
were applied at separate sessions, the significant theta source
activity increment at the ACC associated with the herbal
nasal drop may possibly be due to the activity diﬀerence
at baseline from that of the saline solution. Thus, the same
voxel-by-voxel paired t-test was performed to compare the
baseline theta source activity before the application of the
two types of nasal drops. Results indicated that there was
no significant diﬀerence between the baseline of herbal nasal
drop and that of saline solution at the ACC (t = 1.79 and 1.87
for BA 24 and 32, resp., P > .025). It has, hence, provided
further support for the specific eﬀect of the herbal nasal drop
on the ACC and implicated that the theta source activity at
ACC was relatively stable across time within an individual
during baseline resting state.
4. Discussion
The primary purpose of the present study was to examine
the electrophysiological activities of the brain associated with
the administration of a specific herbal nasal drop. Brain
activities were recorded before and after nasal application
of either the herbal remedy or saline solution. Cordance
(an index correlated with brain perfusion) and LORETA
(localization of theta source activity of the brain) were used
to measure the neural activities of two regions of interest,
namely the frontal lobe and the ACC. The results showed that
immediately after nasal application of the herbal remedy, the
frontal region and the ACC of the brain became more active
as evidenced by increased cordance in the frontal region and
theta source activity at the ACC. On the other hand, brain
activity did not show significant diﬀerence before and after
the administration of the saline solution. Thus, the results
suggested that the specific herbal remedy examined in the
present study seemed to be associated with the increasing
neural activity.
The present study has provided some insights into the
possible mechanism underlying the clinical observation that
patients with frontal lobe dysfunction showed improvement
after taking the herbal remedy. Specifically, some patients
with frontal signs including irritability, expressive diﬃ-
culty, comprehension impairment and behavioral problems
demonstrated various degrees of improvement after 1–4
months of intervention with the herbal remedy. Given that
frontal signs are results of frontal lobe and ACC dysfunction,
any intervention that increases the activities of these two
regions may be able to reduce behavioral impairments due to
frontal lobe dysfunction. The present results demonstrated
that the nasal application of the herbal remedy increased
the activity of the frontal lobe and anterior cingulate cortex,
which seems to be explainable for the clinically observed
improvements in behavioral problems of patients with
frontal lobe dysfunction. Thus, the present findings may
have provided initial empirical support for the possibility
of using this herbal remedy as potential intervention for
enhancing cognitive functions. In fact, an increasing number
of studies have found support for the clinical application
of herbal medicine as possible complementary medicine for
mental disorders [25–35], and the present study has provided
additional support.
While administering herbal medicine through the nose
has been advocated in the traditional Shaolin medical
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Figure 3: Enhanced theta current density in the anterior cingulate cortex (ACC) after the administration of the herbal nasal drop (a), but not
the saline nasal drop (b), as analyzed by the voxel-by-voxel paired t statistics with low-resolution electromagnetic tomography (LORETA),
t(13) = 2.65, P < .025. The figure shows the sagittal images at the level of maximal diﬀerences between the baseline and the post-intranasal
administration time points. The x, y and z Talairach coordinates are −3, 31 and 22, respectively. Red color indicates the source location of
significantly increased electrical activity in the brain at post-intranasal administration.
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Figure 4: Postulated nose-brain pathway of the eﬀect of the herbal nasal drop on enhancing brain activity and the associated cognitive
functions mediated by the frontal and the anterior cingulate brain structures.
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approach, the use of nasal administration of drugs has
received increasing attention in the Western medical litera-
ture during the last decade. Accumulating evidence shows
that administration of drugs through the nasal cavity is
especially eﬀective in delivering drugs to the brain [36–38].
An animal study showed that administration of a variant
form of dopamine in the right nasal cavity of mice was
associated with detection of concentration 27 times higher
in the right than the left olfactory bulb [39]. Evidence from
human studies also suggested that nasal administration of
drugs facilitated the delivery of drugs to the brain. For
example, radioactivity in the brain was observed 5min after
the nasal administration of a radioisotope in one study [40],
and accumulation of insulin was found in the cerebral spinal
fluid after nasal administration of insulin in another study
[41]. One study reported that event-related potentials in the
brain were changed by nasal administration of drugs [42].
The eﬀect of the herbal nasal drop in possibly enhancing
cerebral perfusion in the frontal region as reflected by
increased theta cordance and increasing source activity at the
ACC in normal participants suggests the potential clinical
application and therapeutic eﬀect of the herbal nasal drop
for treating patients with brain disorders. Figure 4 shows
a schematic representation of the possible pathway of how
the herbal nasal drop passes through the nose to influence
the brain activity as reflected by the EEG indices, as well as
the associated cognitive functions mediated by the frontal
lobe and the anterior cingulate brain structures. Intranasal
drug administration has the advantages of being noninvasive,
rapid in its delivery of drug to the central nervous sys-
tem, having enhanced drug absorption properties and easy
accessibility to blood capillaries. To explore the therapeutic
eﬀect of the herbal nasal drop on treating brain disorders,
it is worthwhile to examine its eﬀect on patients with well-
documented brain dysfunction associated with abnormality
in the ACC or frontal lobe. These may include Alzheimer’s
disease which is related to reduced metabolism and brain
atrophy at the cingulate and frontal cortex [43, 44], autistic
spectrum disorders and attention deficit/hyperactivity dis-
order which are related to hypoactivity in the ACC and
frontal region [12] and depression which is associated with
suppressed activation and perfusion in the left prefrontal
cortex [45].
The present study has provided initial evidence for the
eﬀect of the herbal nasal drop on the physiological state of
the brain and on the possible underlying therapeutic nature
of this particular herbal formula. However, it has several
limitations. First, since the electrophysiological activities
were measured immediately after application of the nasal
drop, the duration of the eﬀect of the herbal remedy
remains to be evaluated in further studies. Second, it remains
unclear whether oral administration of the herbal formula,
or application of other herbal formulas, will produce a
similar eﬀect or not. These questions warrant further
investigation. Third, it is by deduction from knowledge
of the localization of attentional and inhibitory control
abilities to the frontal lobe and ACC region [46, 47] that we
postulate that the herbal nasal drop may act on the cognitive
functions involving attentional and inhibitory control. Yet,
this postulation needs further verification in future studies
in which event-related EEG or fMRI assessment will be
administered during diﬀerent cognitive tasks. Fourth, the
recording montage adopted in the present study has not
included the FPz electrode, which has recently been reported
to be specifically sensitive in detecting ACC activity with
LORETA [48]. Inclusion of this electrode may thus be
considered in the future to explore possible added knowledge
about the eﬀect of the herbal nasal drop in ACC. Finally,
although the present study and some clinical studies have
provided evidence to suggest that the herbal nasal drop
may have the potential to become an alternative treatment
for brain disorders, randomized controlled trials have to be
conducted to establish the eﬀect of the herbal nasal drop on
the cognitive functions of patients with brain disorders.
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